CTSOVSHCA• 28 Days (Normalized)
CTSO vs HCA (Cytosorbents Corporation vs HCA Healthcare Inc.)
Showing Closing Date Range from Sep 4 to Oct 2, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
CTSO Performance $4.05
+1057.14%
Cytosorbents Corporation
Normalized Baseline0.00%
HCA Performance $426.69
+5.36%
HCA Healthcare Inc.
Normalized Baseline0.00%
Alpha Spread Margin CTSO LEADS
+1051.78 pts
CTSO outperforming by 1051.78 percentage points
CTSOHCA
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
CTSO HCA
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(19 dates)
| Date | CTSO Price | CTSO Gain (%) | HCA Price | HCA Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 02, 2026 | $4.05 | +1057.14% | $426.69 | +5.36% | +1051.78% |
| Sep 30, 2026 | $3.90 | +1014.29% | $430.43 | +6.28% | +1008.01% |
| Sep 29, 2026 | $4.00 | +1042.86% | $431.63 | +6.58% | +1036.28% |
| Sep 28, 2026 | $4.02 | +1048.57% | $432.60 | +6.81% | +1041.76% |
| Sep 25, 2026 | $4.38 | +1151.43% | $435.61 | +7.56% | +1143.87% |
| Sep 24, 2026 | $4.30 | +1128.57% | $423.48 | +4.56% | +1124.01% |
| Sep 23, 2026 | $4.91 | +1302.86% | $436.48 | +7.77% | +1295.09% |
| Sep 22, 2026 | $- | $438.12 | +8.18% | - | |
| Sep 21, 2026 | $5.51 | +1474.29% | $425.97 | +5.18% | +1469.11% |
| Sep 18, 2026 | $5.75 | +1542.86% | $427.71 | +5.61% | +1537.25% |
| Sep 17, 2026 | $5.76 | +1545.71% | $429.04 | +5.94% | +1539.77% |
| Sep 16, 2026 | $5.73 | +1537.14% | $430.43 | +6.28% | +1530.86% |
| Sep 15, 2026 | $6.06 | +1631.43% | $423.82 | +4.65% | +1626.78% |
| Sep 14, 2026 | $6.07 | +1634.29% | $425.49 | +5.06% | +1629.23% |
| Sep 11, 2026 | $6.41 | +1731.43% | $426.94 | +5.42% | +1726.01% |
Page 1 of 2